rs79120261
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001378609.3(OTOGL):c.5266-7T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0283 in 1,602,594 control chromosomes in the GnomAD database, including 809 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001378609.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOGL | NM_001378609.3 | c.5266-7T>C | splice_region_variant, intron_variant | ENST00000547103.7 | NP_001365538.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOGL | ENST00000547103.7 | c.5266-7T>C | splice_region_variant, intron_variant | 5 | NM_001378609.3 | ENSP00000447211.2 | ||||
OTOGL | ENST00000646859.1 | c.5131-7T>C | splice_region_variant, intron_variant | ENSP00000496036.1 | ||||||
OTOGL | ENST00000298820.7 | c.565-7T>C | splice_region_variant, intron_variant | 5 | ENSP00000298820.3 |
Frequencies
GnomAD3 genomes AF: 0.0205 AC: 3122AN: 152166Hom.: 55 Cov.: 33
GnomAD3 exomes AF: 0.0196 AC: 4609AN: 235408Hom.: 63 AF XY: 0.0202 AC XY: 2578AN XY: 127808
GnomAD4 exome AF: 0.0292 AC: 42280AN: 1450310Hom.: 753 Cov.: 30 AF XY: 0.0287 AC XY: 20672AN XY: 721204
GnomAD4 genome AF: 0.0205 AC: 3123AN: 152284Hom.: 56 Cov.: 33 AF XY: 0.0192 AC XY: 1429AN XY: 74462
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jul 31, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 08, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | 5239-7T>C in intron 43 of OTOGL: This variant is not expected to have clinical s ignificance because it has been identified in 3.3% (268/8158) of European Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs79120261). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at